Page 4 - 2020 Policy Watch-Comparison of Secret Sale Patent
P. 4
icy Watch: Comparison between the US and China as to Whether a Secret Sale before the Date of Filing Affacts the Patent Application
President’s Message
会长致辞
Dear Members, 亲爱的会员,
The following essay gives a detailed comparison on
whether an application on secret sale before the date 本书详细比较分析了中美两国在申请日前进
of filing is patentable in the US and China. It fea- 行秘密销售的专利申请是否可授予专利问
tures the Helsinn Healthcare S.A. v. Teva Pharms. 题在立法、司法上的不同。它围绕Helsinn
USA, Inc. case and points out the different interpre- Healthcare S.A. 诉Teva Pharms. USA, Inc.
tations of related patent laws in US and China. 案的前因后果进行条分缕析，指出了中美两
The analysis was performed under the guidance 国在专利法相关问题上处理方法的不同。
of our IPR Committee Chair and member of our
Board of Governors, Dr. David Buxbaum and his 本书的研究成果是在华南美国商会知识产权
firm, Anderson and Anderson. I am most grateful 委员会主席、华南美国商会理事包恒先生
to David for his generosity and contributions to our 以及他所在的美国安与恩事务所的指导下完
business community. 成。我在此对包恒先生对我们业界的慷慨与
Our Chamber, through its IPR Committee, has for 贡献表示衷心的谢意。
many years led the way in helping to bring about
effective IPR protection in China. While China has 华南美国商会通过属下的知识产权委员会多
made substantial progress in the areas of legislation 年来一直致力于推动有效的在华知识产权
and enforcement, we were highly encouraged by 保护。中国近年来在知识产权领域的立法与
China’s decision that established intellectual prop- 执行均取得重大进展，尤其是最近中国决定
erty courts in Beijing, Shanghai, and Guangzhou. 在北京、上海以及广州设立知识产权法院，
This move is already having a significant impact on 这对于我们来说是极大的鼓舞。这一举措正
the adjudication of IPR disputes in China. With 对在华知识产权纠纷的裁判产生重大的影
more than 90% of IPR cases filed involving Chinese 响。鉴于超过90%的知识产权个案涉及的主
companies against Chinese companies, the intellec- 体均为中国企业，我们相信知识产权法院的
tual property courts are benefiting foreign and Chi- 设立，不仅有利于外国企业，而且有利于中
nese companies alike. AmCham South China will 国企业。华南美国商会将一如既往传播有关
continue to disseminate accurate and up to date in- 中国知识产权法律法规发展的准确、最新信
formation on China’s IPR developments to help our 息，以帮助我商会会员企业在中国的成长和
members expand and grow in China. 发展。
4
President’s Message
会长致辞
Dear Members, 亲爱的会员,
The following essay gives a detailed comparison on
whether an application on secret sale before the date 本书详细比较分析了中美两国在申请日前进
of filing is patentable in the US and China. It fea- 行秘密销售的专利申请是否可授予专利问
tures the Helsinn Healthcare S.A. v. Teva Pharms. 题在立法、司法上的不同。它围绕Helsinn
USA, Inc. case and points out the different interpre- Healthcare S.A. 诉Teva Pharms. USA, Inc.
tations of related patent laws in US and China. 案的前因后果进行条分缕析，指出了中美两
The analysis was performed under the guidance 国在专利法相关问题上处理方法的不同。
of our IPR Committee Chair and member of our
Board of Governors, Dr. David Buxbaum and his 本书的研究成果是在华南美国商会知识产权
firm, Anderson and Anderson. I am most grateful 委员会主席、华南美国商会理事包恒先生
to David for his generosity and contributions to our 以及他所在的美国安与恩事务所的指导下完
business community. 成。我在此对包恒先生对我们业界的慷慨与
Our Chamber, through its IPR Committee, has for 贡献表示衷心的谢意。
many years led the way in helping to bring about
effective IPR protection in China. While China has 华南美国商会通过属下的知识产权委员会多
made substantial progress in the areas of legislation 年来一直致力于推动有效的在华知识产权
and enforcement, we were highly encouraged by 保护。中国近年来在知识产权领域的立法与
China’s decision that established intellectual prop- 执行均取得重大进展，尤其是最近中国决定
erty courts in Beijing, Shanghai, and Guangzhou. 在北京、上海以及广州设立知识产权法院，
This move is already having a significant impact on 这对于我们来说是极大的鼓舞。这一举措正
the adjudication of IPR disputes in China. With 对在华知识产权纠纷的裁判产生重大的影
more than 90% of IPR cases filed involving Chinese 响。鉴于超过90%的知识产权个案涉及的主
companies against Chinese companies, the intellec- 体均为中国企业，我们相信知识产权法院的
tual property courts are benefiting foreign and Chi- 设立，不仅有利于外国企业，而且有利于中
nese companies alike. AmCham South China will 国企业。华南美国商会将一如既往传播有关
continue to disseminate accurate and up to date in- 中国知识产权法律法规发展的准确、最新信
formation on China’s IPR developments to help our 息，以帮助我商会会员企业在中国的成长和
members expand and grow in China. 发展。
4
